Victoria Link Ltd.
51Patents
48Active
51Granted
56Portfolio score
Filing activity: Feb 11, 2002 → Sep 30, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9865862B2 | Safety material and system | Emerging Cross-Sectional Technologies | 11 | Active |
| US7332095B2 | Wet oxidation | Emerging Cross-Sectional Technologies | 8 | Expired |
| US9522159B2 | Treatment and prevention of P. aeruginosa infections using coformycin analogs | Physics | 3 | Active |
| US7391215B2 | NMR apparatus | Physics | 3 | Expired |
| US9290501B2 | Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase | Chemistry; Metallurgy | 3 | Active |
| US9493465B2 | 3-hydroxypyrrolidine inhibitors of 5′-methylthioadenosine phosphorylase and nucleosidase | Emerging Cross-Sectional Technologies | 3 | Active |
| US9764037B2 | Conjugate compounds | Human Necessities | 1 | Active |
| US9995750B2 | Methods of detecting and measuring glutamine and analogues thereof, and methods related thereto | Physics | 1 | Active |
| US10046046B2 | Amino sphingoglycolipid analogues | Human Necessities | 1 | Active |
| US10983045B2 | Spectrometer apparatus for measuring spectra of a liquid sample using an integrating cavity | Physics | 1 | Active |
| US11237234B2 | MRI magnet and apparatus | Human Necessities | 1 | Active |
| US11217743B2 | Rare earth nitride structures and devices and method for removing a passivating capping | Electricity | 1 | Active |
| US11324742B2 | Treatment of demyelinating diseases | Human Necessities | 1 | Active |
| US10118928B2 | Treatment of H. pylori infections using MTAN inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US12196631B2 | Optical fibre sensing system and method | Electricity | 0 | Active |
| US10294233B2 | Treatment of H. pylori infections using MTAN inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US11055830B2 | Rendering process and system | Physics | 0 | Active |
| US10725049B2 | Methods of detecting and measuring glutamine and analogues thereof, and methods related thereto | Physics | 0 | Active |
| US11034679B2 | Agonists of the mu opioid receptor | Human Necessities | 0 | Active |
| US10227351B2 | Salt and polymorphic forms of (3R,4S)-L-((4-amino-5H-pyrrolo[3,2,-D]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(MTDIA) | Chemistry; Metallurgy | 0 | Active |
| US11186575B2 | Treatment of helicobacter pylori infections | Emerging Cross-Sectional Technologies | 0 | Active |
| US9956198B2 | Furo[3,4-b]pyran compounds and pharmaceutical uses | Chemistry; Metallurgy | 0 | Active |
| US10357577B2 | Bacterial nitroreductase enzymes and methods relating thereto | Emerging Cross-Sectional Technologies | 0 | Active |
| US9717790B2 | Sphingoglycolipid analogues | Human Necessities | 0 | Active |
| US11453882B2 | Heterologous biosynthesis of nodulisporic acid | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.